Delivery Order SPE2DB22D3501-SPE2DB24FWU01

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4563681465 - Hydrocortisone Val 0.2% Ointment, 15 gm, with a ceiling value of $2,618. It is a firm fixed price delivery order contract with a completion date of February 16, 2024. The award was made on February 15, 2024, and there was no set-aside designation. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HYDROCORTISONE VAL 0.2% OINTMT 15GM. The contract is a firm fixed-price delivery order with a ceiling value of $2,685.96 and a completion date of May 20, 2025. This award is not set aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support...
This is a delivery order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $2,530.08 firm fixed-price delivery order is for the supply of 15-gram tubes of 0.2% hydrocortisone ointment. The award is not designated as a set-aside contract. The DLA IDC, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract, valued at $11,358.44, is for the delivery of 15 gram tubes of 0.2% hydrocortisone ointment. The contract has an ultimate completion date of March 27, 2025 and was awarded on March 26, 2025. The contract is a firm fixed price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, with no major subcontractors mentioned. This contract...
This federal contract award, valued at $1,013.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Hydrocortisone Valerate 0.2% Ointment, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of June 15, 2023. It is not designated as a set-aside contract, indicating open competition....
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,125.85 firm-fixed-price contract is for the delivery of 4556497960 - Hydrocortisone Valerate 0.2% Ointment, 45g tubes. The award has no set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which serves as a critical...
This federal contract award is for the delivery of Hydrocortisone Valerate 0.2% Ointment in 45 gram tubes. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 5, 2021. The contract is a Delivery Order with a Firm Fixed Price of $3,348.76 and has an Ultimate Completion Date of August 6, 2021. The contract is not associated with any set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the...
This federal contract award is for the delivery of Hydrocortisone Valerate 0.2% Ointment, 15 grams, to the Defense Logistics Agency (DLA). The contract, valued at $1,003.73, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on May 10, 2023, with a completion date of May 11, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,874.14, is for the delivery of 15 gram tubes of 0.2% hydrocortisone ointment. The contract has an ultimate completion date of December 14, 2023 and is a firm fixed price Delivery Order. No set-aside designation was used for this award. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565504630 - Hydrocortisone Valerate 0.2% Ointment, 60 grams. The contract has a ceiling value of $4,837.64 and a period of performance through August 20, 2024. The award is not set-aside. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical commodities, including prescription drugs, vaccines, and medical supplies, to...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWU01
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565586382 - Hydrocortisone Valerate 0.2% Ointment in 15 gram tubes. The contract has a ceiling value of $1,882.38 and an ultimate completion date of August 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/25/24, 9:19 AM